PAPER Stamelou M, de Silva R, Arias-Carrión O, Boura E, Höllerhage M, Oertel WH, Müller U, Höglinger GU

Rational therapeutic approaches to progressive supranuclear palsy.

Brain. 2010 Jun;133(Pt 6):1578-90. PubMed: 20472654

PAPER Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S, Brandner S

Tau, prions and Aβ: the triad of neurodegeneration.

Acta Neuropathol. 2011 Jan;121(1):5-20. PubMed: 20473510

PAPER Lin YF, Xu X, Cape A, Li S, Li XJ

Huntingtin-associated protein-1 deficiency in orexin-producing neurons impairs neuronal process extension and leads to abnormal behavior in mice.

J Biol Chem. 2010 May 21;285(21):15941-9. PubMed: 20304926

PAPER Glazner KA, Odero GL, Anema E, Motnenko A, Schapansky J, Grossman D, Oliver DR, Glazner GW, Albensi BC

Strain specific differences in memory and neuropathology in a mouse model of Alzheimer's disease.

Life Sci. 2010 Jun 19;86(25-26):942-50. PubMed: 20470790

PAPER Malaspina A, Ngoh SF, Ward RE, Hall JC, Tai FW, Yip PK, Jones C, Jokic N, Averill SA, Michael-Titus AT, Priestley JV

Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis.

Neuroscience. 2010 Aug 25;169(2):812-27. PubMed: 20470869

PAPER Bender C, de Olmos S, Bueno A, de Olmos J, Lorenzo A

Comparative analyses of the neurodegeneration induced by the non-competitive NMDA-receptor-antagonist drug MK801 in mice and rats.

Neurotoxicol Teratol. 2010 Sep-Oct;32(5):542-50. PubMed: 20470881

PAPER Furukawa A, Oikawa S, Hasegawa-Ishii S, Chiba Y, Kawamura N, Takei S, Yoshikawa K, Hosokawa M, Kawanishi S, Shimada A

Proteomic analysis of aging brain in SAMP10 mouse: a model of age-related cerebral degeneration.

Mech Ageing Dev. 2010 Jun;131(6):379-88. PubMed: 20471994

PAPER Schnabel J

Protein folding: The dark side of proteins.

Nature. 2010 Apr 8;464(7290):828-9. PubMed: 20376124

PAPER Wisniewski T, Sigurdsson EM

Murine models of Alzheimer's disease and their use in developing immunotherapies.

Biochim Biophys Acta. 2010 Oct;1802(10):847-59. PubMed: 20471477

Miguel Rodríguez-Manotas on Toward structural elucidation of the gamma-secretase complex.

COMMENT The presenilin hypothesis should be explained taken into account the latest findings from the three-dimensional structure of secretase complex and the monomeric condition. If the water channels were, in fact, two distinct channels through which the same m

Deborah Blacker on NIH Calls for More (and Different) Research on Preventive Measures

COMMENT With regard to the big picture, I agree with John Breitner that RCTs have largely focused on treatment of established AD. A few have looked at MCI, but it has been defined at a high threshold, such that the likelihood of progression to dementia in a few y

Susan Resnick

NIA
Baltimore, United States

Cassondra Kowalski

Germany

Tau TAUY5

ANTIBODY polyclonal manufacturer Cat# AHB0351 immunogen = synthetic peptide, corresp. to aa residues 186-201 of human tau protein isoform 6 (GEPPKSGDRSG-pY-SSPG), conj. to KLH via an N-terminal cysteine residue liquid, purified Ig, PBS, azide detects both non-phos

Tau TAUY7

ANTIBODY polyclonal manufacturer Cat# AHB0381 immunogen = synthetic peptide, corresp. to aa residues 384-397 of human tau protein isoform 6 (AKTDHGAEIV-pY-KSP), conj. to KLH via an N-terminal cysteine residue liquid, purified Ig, PBS, azide detects both non-phosph